The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...
Recalls on a brand of broccoli and chocolate from December were recently upgraded to Class I, the highest risk level issued ...
The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...
The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.
The U.S. Food and Drug Administration (FDA) has given its second most serious risk level, Class II, to a product from D. Coluccio & Sons. The recalled product is a 300 gram pack of chocolate chip ...
According to the FDA, If consumers have an allergy or sensitivity to milk, they should not consume the product and discard it ...
The snacks are now part of a Class I recall, which is for products with the potential of "serious adverse health consequences ...
The US Food and Drug Administration has approved the use of a novel painkiller as an effective treatment for short-term ...
The FDA has upgraded a recall of Lay’s Potato Chips to the highest level possible, meaning consuming the chips will cause ...
Suzetrigine selectively inhibits the NaV1.8 pain-signaling pathway in the peripheral nervous system and provides effective ...
The greenlight for Journavx (suzetrigine), which comes on the heels of a $7.4 billion opioid settlement, could spark momentum ...
The Food and Drug Administration has upgraded its classification of a broccoli recall initially reported in late December, ...